CorMedix Inc. (CorMedix Inc. (CRMD) is higher by Tuesday morning, with the stock gaining 8.61% in pre-market trading to 7.44.
CRMD's short-term technical score of 19 indicates that the stock has traded less bullishly over the last month than 81% of stocks on the market. In the Biotechnology industry, which ranks 125 out of 146 industries, CorMedix Inc. ranks higher than 31% of stocks.
CorMedix Inc. has fallen 54.21% over the past month, closing at $14.10 on February 9. During this period of time, the stock fell as low as $6.84 and as high as $18.80. CRMD has an average analyst recommendation of Strong Buy. The company has an average price target of $21.30.
CorMedix Inc. has a Long-Term Technical rank of 15. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 85% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, CRMD ranks better than 23% of stocks.
Important Dates for Investors in CRMD:
-CorMedix Inc. is set to release earnings on 3/15/2021. During their last earnings release the company posted EPS of $-0.75. -We do not have a set dividend date for CorMedix Inc. at this time. Click Here to get the full Stock Score Report on CorMedix Inc. (CRMD) Stock.